Finance

Beta
Lists
ACXP:NASDAQ
Acurx Pharmaceuticals Inc
$1.52
+7.04%
(+0.10) 1D
$1.48
-2.63% (-0.040)
After hours
Closed: Jun 26, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACXP...
Open
$1.42
High
$1.57
Low
$1.42
Mkt. cap
6.53M
Avg. vol.
88.17K
Volume
44.80K
52-wk high
$11.73
52-wk low
$1.33
EPS
-$4.46
Beta
-2.09
Shares outstanding
4.30M
No. of employees
4
Open
$1.42
High
$1.57
Low
$1.42
Mkt. cap
6.53M
Avg. vol.
88.17K
Volume
44.80K
52-wk high
$11.73
52-wk low
$1.33
EPS
-$4.46
Beta
-2.09
Shares outstanding
4.30M
No. of employees
4
News stories
From sources across the web
About Acurx Pharmaceuticals Inc
CEODavid P Luci
Employees4
Founded2017
Headquarters-
SectorBiotechnology
Analyst ratings
Based on 3 analysts giving stock ratings to ACXP in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ACXP in the last 3 months.
Highest
Current $1.52
$31.00 (+1,939.47%)
Average
$17.00 (+1,018.42%)
Lowest
$10.00 (+557.89%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$10.00
+557.9%
05/12/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$10.00
+557.9%
05/13/2026
Matthew Keller
H.C. Wainwright
Buy
Reiterated
$31.00
+1,939.5%
05/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
524.21K
429.69K
281.81K
341.47K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.75M
1.60M
1.34M
1.37M
Operating expense
2.27M
2.03M
1.62M
1.72M
Total operating expenses
2.27M
2.03M
1.62M
1.72M
Operating income
-2.27M
-2.03M
-1.62M
-1.72M
Other non operating income
-
-
-
-
EBT including unusual items
-2.25M
-1.99M
-1.58M
-1.68M
EBT excluding unusual items
-2.25M
-1.99M
-1.58M
-1.68M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.25M
-1.99M
-1.58M
-1.68M
Net profit margin
-
-
-
-
Earnings per share
-1.89
-1.23
-0.31
-0.62
Interest and investment income
23.40K
35.91K
38.84K
35.01K
Interest expense
-
-
-
-
Net interest expenses
23.40K
35.91K
38.84K
35.01K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
Give me an overview of ACXP
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more